159583-33-2 Usage
Uses
Used in Pharmaceutical Research:
1(2H)-Pyridazineacetonitrile, tetrahydro-2-methyl-(9CI) is used as a building block in pharmaceutical research for the synthesis of various bioactive compounds. Its unique structure and reactivity contribute to the development of new drugs and pharmaceuticals.
Used in Organic Synthesis:
In the field of organic synthesis, 1(2H)-Pyridazineacetonitrile, tetrahydro-2-methyl-(9CI) is used as an intermediate in the production of other chemicals. Its versatile nature allows for the creation of a wide range of chemical products, making it a valuable tool in the study and application of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 159583-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,5,8 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 159583-33:
(8*1)+(7*5)+(6*9)+(5*5)+(4*8)+(3*3)+(2*3)+(1*3)=172
172 % 10 = 2
So 159583-33-2 is a valid CAS Registry Number.
159583-33-2Relevant academic research and scientific papers
Synthesis of p-aminobenzamides of aminopiperidazines as potential antiarrhythmic agents
Kornet,Abdul-Nabi Ali,Steinberg
, p. 967 - 971 (2007/10/02)
1,2-Dimethyl-4-aminopiperidazine (4), 1-(2-aminoethyl)-2-methylpiperidazine (11), 2-(2-aminoethyl)-3-methyl-2,3-diazabicyclo[2.2.1]heptane (16), and 1,2-dimethyl-3-aminomethylpiperidazine (21) have been synthesized. Amines 4, 11, and 16 were converted to the corresponding p-nitrobenzamides 7, 12, and 17. Catalytic reduction of the latter nitro derivatives gave the corresponding p-aminobenzamides 8, 13, and 18. For comparative studies, the acyclic analog, 4-amino-N-[2-(1,1,2-trimethylhydrazino)ethyl]benzamide (25) was also synthesized. Compounds 8, 13 and 25 which are analogs of procainamide were evaluated in the isolated cardiac Purkinje fiber preparation by measuring their effects on the action potential upstroke velocity.